Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Abramson

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Leukemia & Lymphoma|October 19, 2007
Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: final results of E1497Timothy M Kuzel, Shuli Li, John Eklund, et al.
Cancer Investigation|November 23, 2006
A pilot phase II trial of valspodar modulation of multidrug resistance to paclitaxel in the treatment of metastatic carcinoma of the breast (E1195): a trial of the Eastern Cooperative Oncology GroupRobert W Carlson, Anne M O'Neill, Lori J Goldstein, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Leukemia & Lymphoma|October 19, 2007
Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: final results of E1497Timothy M Kuzel, Shuli Li, John Eklund, et al.
Cancer Investigation|November 23, 2006
A pilot phase II trial of valspodar modulation of multidrug resistance to paclitaxel in the treatment of metastatic carcinoma of the breast (E1195): a trial of the Eastern Cooperative Oncology GroupRobert W Carlson, Anne M O'Neill, Lori J Goldstein, et al.
Pageof 2